These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 15913037)

  • 41. Associations between copper and zinc intakes from diet and mortality from cardiovascular disease in a large population-based prospective cohort study.
    Eshak ES; Iso H; Yamagishi K; Maruyama K; Umesawa M; Tamakoshi A
    J Nutr Biochem; 2018 Jun; 56():126-132. PubMed ID: 29529560
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Australian epidemic of cardiovascular mortality 1935-2005: effects of period and birth cohort.
    Taylor R; Page A; Danquah J
    J Epidemiol Community Health; 2012 Jul; 66(7):e18. PubMed ID: 21282145
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Knowledge of cardiovascular disease risk factors and the risk of death in middle-aged residents of Krakow.
    Waśniowska A; Kozela M; Podolec P; Pająk A
    Kardiol Pol; 2017; 75(4):386-394. PubMed ID: 27995599
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Burden of cardiovascular disease in Canada.
    Manuel DG; Leung M; Nguyen K; Tanuseputro P; Johansen H;
    Can J Cardiol; 2003 Aug; 19(9):997-1004. PubMed ID: 12915926
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chronic kidney disease and risk of incident myocardial infarction and all-cause and cardiovascular disease mortality in middle-aged men and women from the general population.
    Meisinger C; Döring A; Löwel H;
    Eur Heart J; 2006 May; 27(10):1245-50. PubMed ID: 16611670
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Low physical activity as a predictor for total and cardiovascular disease mortality in middle-aged men and women in Finland.
    Barengo NC; Hu G; Lakka TA; Pekkarinen H; Nissinen A; Tuomilehto J
    Eur Heart J; 2004 Dec; 25(24):2204-11. PubMed ID: 15589637
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Mortality in primary malignant brain tumors in the population of Belgrade].
    Pekmezović T; Jarebinski M; Kisić D; Pavlović M; Nikitović M; Knezević A; Vujković B
    Vojnosanit Pregl; 2003; 60(5):565-8. PubMed ID: 14608834
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The treatment of coronary heart disease: an update. Part 2: Mortality trends and main causes of death in the Greek population.
    Chimonas ET
    Curr Med Res Opin; 2001; 17(1):27-33. PubMed ID: 11464442
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Primary liver cancer mortality in Belgrade population].
    Kanazir M; Jarebinski M; Delić D; Boricić I; Gledović Z; Pekmezović T
    Acta Chir Iugosl; 2004; 51(3):105-10. PubMed ID: 16018376
    [TBL] [Abstract][Full Text] [Related]  

  • 50. C-reactive protein in the prediction of cardiovascular and overall mortality in middle-aged men: a population-based cohort study.
    Laaksonen DE; Niskanen L; Nyyssönen K; Punnonen K; Tuomainen TP; Salonen JT
    Eur Heart J; 2005 Sep; 26(17):1783-9. PubMed ID: 15821003
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Exercise capacity and mortality - a follow-up study of 3033 subjects referred to clinical exercise testing.
    Korpelainen R; Lämsä J; Kaikkonen KM; Korpelainen J; Laukkanen J; Palatsi I; Takala TE; Ikäheimo TM; Hautala AJ
    Ann Med; 2016 Aug; 48(5):359-66. PubMed ID: 27146022
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neutral associations of testosterone, dihydrotestosterone and estradiol with fatal and non-fatal cardiovascular events, and mortality in men aged 17-97 years.
    Chan YX; Knuiman MW; Hung J; Divitini ML; Beilby JP; Handelsman DJ; Beilin J; McQuillan B; Yeap BB
    Clin Endocrinol (Oxf); 2016 Oct; 85(4):575-82. PubMed ID: 27106765
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cardiovascular disease mortality in Canada.
    Nicholls ES; Jung J; Davies JW
    Can Med Assoc J; 1981 Nov; 125(9):981-92. PubMed ID: 7332895
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fifteen-year mortality trends due to cardiovascular diseases in Poland using standard expected years of life lost, 2000-2014.
    Pikala M; Maniecka-Bryła I
    Kardiol Pol; 2017; 75(10):1033-1040. PubMed ID: 28715075
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Annual and seasonal trends in mortality rates from cardiovascular diseases in Hungary between 1984 and 2013.
    Virág K; Nyári TA
    Cent Eur J Public Health; 2018 Jun; 26(2):124-131. PubMed ID: 30102501
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Epidemiological and clinical characteristics of myasthenia gravis in Belgrade, Yugoslavia (1983-1992).
    Lavrnić D; Jarebinski M; Rakocević-Stojanović V; Stević Z; Lavrnić S; Pavlović S; Trikić R; Tripković I; Nesković V; Apostolski S
    Acta Neurol Scand; 1999 Sep; 100(3):168-74. PubMed ID: 10478580
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Major cardiovascular diseases mortality in Kaunas population for 1983-2002].
    Radishauskas R; Bernotene G; Shopagene D; Rastenite D
    Ter Arkh; 2005; 77(1):34-7. PubMed ID: 15759451
    [TBL] [Abstract][Full Text] [Related]  

  • 58. C-reactive protein and risk of cardiovascular and all-cause mortality in 268 803 East Asians.
    Sung KC; Ryu S; Chang Y; Byrne CD; Kim SH
    Eur Heart J; 2014 Jul; 35(27):1809-16. PubMed ID: 24569028
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [An evaluation of the impact of cardiovascular disease prevention in Portugal (1980-1996). A longitudinal Gompertzian analysis of mortality].
    Cardoso SM
    Rev Port Cardiol; 2000 Mar; 19(3):333-42. PubMed ID: 10804779
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Trends in major risk factors and mortality from main non-communicable diseases in Lithuania, 1985-2013.
    Tamosiunas A; Klumbiene J; Petkeviciene J; Radisauskas R; Vikhireva O; Luksiene D; Virviciute D
    BMC Public Health; 2016 Aug; 16():717. PubMed ID: 27492379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.